Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs

Melita Moioli, Fabio Barra, Mattia Maramai, Mario Valenzano Menada, Valerio Gaetano Vellone, Sergio Costantini, Simone Ferrero

Research output: Contribution to journalArticle

Original languageEnglish
JournalExpert Opinion on Investigational Drugs
DOIs
Publication statusAccepted/In press - Jan 1 2019

Keywords

  • chemoresistance
  • genetic mutations
  • KRAS
  • molecular pathways
  • Mucinous epithelial ovarian cancer
  • targeted therapy

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this